New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Natera, Inc.
NTRA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

16B

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

16B

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

130.06USD
Shape4.31 ( 3.43%)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

-35%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated October 13, 2024
1W 1.45 % 1M 0.30 % 3M 15.44 % 1Y 207.25 %

Key Metrics

Shape
  • Market Cap

    16.09B


  • Shares Outstanding

    123.68M


  • Share in Float

    116.25M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    130.06


  • Average Volume

    1.42M


  • Beta

    1.529


  • Range

    36.9-133.539


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.natera.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

11.82x

P/S Ratio

19.10x

P/B Ratio

0.4

Debt/Equity

-21.5%

Net Margin

$-2.4

EPS

How NTRA compares to sector?

P/E Ratio

Relative Strength

Shape

NTRA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape313%

2025-Revenue

$1.23

Shape-310%

2025-EPS

$930M

Shape-2483%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

initialise

Previous: Not converted

2024-06-03

Now: Buy

Bernstein

upgrade

Previous: Not converted

2024-04-05

Now: Outperform

Raymond James

upgrade

Previous: Not converted

2023-11-13

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.25
vs -1.63

Q4.22

arrow
arrow

N/A

-1.37
vs -1.48

Q1.23

arrow
arrow

N/A

-1.23
vs -1.45

Q2.23

arrow
arrow

N/A

-0.97
vs -1.50

Q3.23

arrow
arrow

N/A

-0.95
vs -1.25

Q4.23

arrow
arrow

N/A

-0.64
vs -1.37

Q1.24

arrow
arrow

N/A

-0.56
vs -1.23

Q2.24

arrow
arrow

N/A

-0.30
vs -0.97

Q3.24

arrow
arrow

N/A

-0.57
vs -0.95

Q4.24

arrow
arrow

N/A

-0.53
vs -0.64

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+33%

210.6M  vs 158.1M

Q4.22

arrow
arrow

+26%

217.3M  vs 173M

Q1.23

arrow
arrow

+25%

241.8M  vs 194.1M

Q2.23

arrow
arrow

+32%

261.4M  vs 198.2M

Q3.23

arrow
arrow

+27%

268.3M  vs 210.6M

Q4.23

arrow
arrow

+43%

311.1M  vs 217.3M

Q1.24

arrow
arrow

+52%

367.7M  vs 241.8M

Q2.24

arrow
arrow

+58%

413.4M  vs 261.4M

Q3.24

arrow
arrow

+35%

361.8M  vs 268.3M

Q4.24

arrow
arrow

+20%

374.7M  vs 311.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-34%

-0.34
vs -0.33

Q4.22

arrow
arrow

-20%

-0.20
vs -0.34

Q1.23

arrow
arrow

-21%

-0.21
vs -0.20

Q2.23

arrow
arrow

-19%

-0.19
vs -0.21

Q3.23

arrow
arrow

-14%

-0.14
vs -0.19

Q4.23

arrow
arrow

-10%

-0.10
vs -0.14

Q1.24

arrow
arrow

-9%

-0.09
vs -0.10

Q2.24

arrow
arrow

-4%

-0.04
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

296

296
vs 263

13%

Q4.22

arrow
arrow

293

293
vs 296

-1%

Q1.23

arrow
arrow

335

335
vs 293

14%

Q2.23

arrow
arrow

323

323
vs 335

-4%

Q3.23

arrow
arrow

330

330
vs 323

2%

Q4.23

arrow
arrow

364

364
vs 330

10%

Q1.24

arrow
arrow

425

425
vs 364

17%

Q2.24

arrow
arrow

479

479
vs 425

13%

Earnings Growth

Latest News